CHANGES IN CYTOKINES LEVELS IN ASTHMA PATIENTS WITH FREQUENT EXACERBATIONS
Nội dung chính của bài viết
Tóm tắt
Objectives: To evaluate changes in serum levels of some cytokines in asthma patients with frequent exacerbations. Methods: A prospective, descriptive, longitudinal study on 60 asthma patients with frequent exacerbations and 60 ones with few exacerbations, treated as outpatients at the Asthma Management Department, Hai Phong International Hospital from January 2020 to May 2023. Patients underwent clinical examination, chest X-ray, respiratory function test, and assessment of inflammatory markers and serum cytokine levels at the time of the study. Results: The asthma group with frequent exacerbations had significantly higher IL-4 and IL-13 concentrations than the asthma group with few exacerbations (21.10 and 9.93 pg/mL vs. 16.48 and 3.95 pg/mL). Concentrations of IFN-α, IFN-γ, IL-17, and inflammatory cytokines (IL-12, TNF-α, IL-1β) were not different between the 2 asthma groups. In the asthma group with frequent exacerbations, most serum cytokine concentrations in male patients were insignificantly higher than in females, except for IL-12. IL-17, IFN-α, IL-4, and IL-12 concentrations in patients aged ≥ 60 years were insignificantly higher than those in the group < 60 years old. Conclusion: There are significantly higher serum levels of IL-4 and IL-13 in asthma patients with frequent exacerbations compared to those with few exacerbations.
Chi tiết bài viết
Từ khóa
Frequent exacerbation asthma, Serum cytokine levels
Tài liệu tham khảo
2. Wener RRL and Bel EH. Severe refractory asthma: An update. European Respiratory Review. 2013; 22(129): 227-235.
3.GINA-2019-main-Pocket-Guide-wms.pdf. .
4. Bộ Y tế. Hướng dẫn chẩn đoán và điều trị hen phế quản người lớn và trẻ em ≥ 12 tuổi. Số 1851/QQĐ-BYT, ngày 24 tháng 4 năm 2020.
5. Ten Brinke A. Risk factors of frequent exacerbations in difficult-to-treat asthma. European Respiratory Journal. 2005; 26(5):812-818.
6. Kim MA, Shin SW, Park JS, et al. Clinical characteristics of exacerbation- prone adult asthmatics identified by cluster analysis. Allergy Asthma Immunol Res. 2017; 9(6):483.
7. Wenzel S, Ford L, Pearlman D, et al. Dupilumab in persistent asthma with elevated eosinophil levels. N Engl J Med. 2013; 368(26):2455-2466.
8. Djukanović R, Harrison T, Johnston SL, et al. The effect of inhaled IFN-β on Worsening of asthma symptoms caused by viral infections: A randomized trial. Am J Respir Crit Care Med. 2014; 190(2):145-154.
9. Han YY, Forno E, and Celedón JC. Sex steroid hormones and asthma in a nationwide study of U.S. adults. Am J Respir Crit Care Med. 2020; 201(2):158-166.
10. Yung JA, Fuseini H, and Newcomb DC. Hormones, sex, and asthma. Annals of Allergy, Asthma & Immunology. 2018; 120(5):488-494.
11. Newcomb DC, Cephus JY, Boswell MG, et al. Estrogen and progesterone decrease Let-7f miRNA expression and increase IL-23/IL-23R signaling and IL-17A production in severe asthma. J Allergy Clin Immunol. 2015; 136(4):1025-1034.e11.
12. Ulambayar B, Lee SH, Yang EM, et al. Association between epithelial cytokines and clinical phenotypes of elderly asthma. Allergy Asthma Immunol Res. 2018; 11(1):79-89.